What is MCAL Therapeutics worth?
$24.0Mlast known valuation
MCAL Therapeutics last raised $5.9M in its Early Stage VC (Mar 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for MCAL Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Mar 2024 | Early Stage VC | $5.9M | ▮ | ▮ |
How MCAL Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For MCAL Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is MCAL Therapeutics worth?
- MCAL Therapeutics's last known valuation is $24.0M.
- How much has MCAL Therapeutics raised?
- MCAL Therapeutics has raised $11.3M in total funding across 1 recorded rounds.
- When did MCAL Therapeutics last raise?
- MCAL Therapeutics last raised in Mar 2024 (Early Stage VC), raising $5.9M.